If two or more antidepressants haven’t worked for you, you are not out of options. Treatment-resistant depression (TRD) responds to a range of proven approaches – including Spravato® (esketamine) nasal spray, targeted medication adjustments, and structured therapy.
At Revival Psychiatry in Mesa, AZ, this is exactly the situation we see most often: people who have followed every instruction, taken every pill as prescribed, and still feel flat, heavy, and disconnected. Depression that resists treatment isn’t proof something is permanently wrong with you – it usually means the mechanism driving your depression hasn’t been matched with the right treatment yet.
TRD is major depressive disorder that hasn’t improved meaningfully after at least two adequate trials of antidepressant medication from different classes. The word “adequate” matters: a trial only counts if you took the medication at a therapeutic dose for a long enough stretch – usually six to eight weeks – and still saw little or no benefit.
That definition rules out more people than you’d expect:
A medication was stopped early because of side effects
The dose never reached a level that could realistically work
An underlying condition – bipolar disorder, thyroid problems, untreated insomnia – was quietly blocking progress
Roughly one in three people with major depression will meet criteria for treatment resistance at some point. Sorting this out is one of the first things we do during a psychiatric evaluation.
The symptoms of TRD are the symptoms of depression – but they persist despite treatment and often deepen over time:
Persistent low mood, sadness, emptiness, or hopelessness most of the day, most days
Loss of interest or pleasure in work, hobbies, relationships, or food you once enjoyed
Fatigue that sleep doesn’t fix – waking up as tired as when you went to bed
Difficulty concentrating, thinking, or making decisions, often described as brain fog
Sleep disruption in either direction: sleeping far too much or lying awake for hours
Appetite or weight changes
Feelings of worthlessness, guilt, or being a burden
Physical symptoms like unexplained aches, headaches, or digestive trouble
Recurrent thoughts of death or suicide
There’s no blood test or brain scan that confirms TRD. Diagnosis comes from a careful, detailed history – and the quality of that history determines the quality of everything that follows.
A thorough evaluation at our Mesa office covers:
Your complete medication history. Which antidepressants, at what doses, for how long, and what happened – no effect, partial effect, or intolerable side effects. Reconstructing this in one place often reveals gaps worth revisiting.
Diagnostic reassessment. Around 20 to 30 percent of people labeled treatment-resistant actually have bipolar disorder that hasn’t been recognized. We also screen for ADHD, PTSD, anxiety disorders, and eating disorders.
Medical screening. Thyroid function, vitamin levels, anemia, sleep disorders, and hormonal factors.
Symptom measurement. Standardized rating scales give us a baseline number, so we can tell real improvement from a slightly better week.
Life context. Sleep, work stress, relationships, substance use, trauma history, and current supports.
SSRIs and SNRIs help millions of people and remain a reasonable starting point for depression treatment. But their limitations are well documented:
They’re slow. Most take four to eight weeks to produce a noticeable effect – and if the medication fails, you’ve spent two months to learn that.
They don’t work for everyone. Only about a third of patients achieve full remission on their first antidepressant, and the odds drop with each subsequent trial.
Side effects drive people away. Weight gain, sexual dysfunction, emotional numbness, and fatigue end many trials early. Feeling nothing is not the same as feeling well.
Incomplete remission. Even when they help, many people only see partial symptom reduction and never fully return to themselves.
Medication isn’t a dead end. Strategic adjustments – switching drug classes, adding a second agent, or augmenting with lithium, thyroid hormone, or an atypical antipsychotic – help a meaningful number of people. That’s the work of thoughtful medication management: doses adjusted deliberately and monitored closely, not left on autopilot for years.
Medication and therapy work through different mechanisms, and combining them consistently outperforms either alone for moderate to severe depression.
Cognitive behavioral therapy interrupts the automatic thoughts that keep depression running
Behavioral activation re-engages you with meaningful activities before motivation returns
Interpersonal therapy addresses relationship patterns and role transitions that feed depressive episodes
Trauma-focused approaches are essential when early adversity is part of the picture
Spravato (esketamine) is an FDA-approved prescription nasal spray developed specifically for adults with treatment-resistant depression. It targets the brain’s glutamate system rather than serotonin, helping restore synaptic connections damaged by chronic stress – which explains why it can help people who saw nothing from multiple SSRIs.
What Spravato treatment at our Mesa clinic involves:
Rapid relief. Many patients notice improvement within hours to days of the first few sessions, versus weeks or months for traditional antidepressants
Clinically supervised setting. Administered in our comfortable Mesa office, always alongside an oral antidepressant
Two-hour monitoring. Patients are observed on site after each dose, then arrange a ride home
A tapering schedule. Treatment begins with twice-weekly sessions and moves to less frequent maintenance visits as symptoms improve
Candidacy review first. Certain cardiovascular conditions, a history of psychosis, and pregnancy need review – treatment always starts with a consultation, never a same-day dose
Neuromodulation treats depression by directly influencing brain activity rather than altering chemistry through the bloodstream. Transcranial magnetic stimulation (TMS) is an evidence-based neuromodulation technique that uses targeted magnetic pulses to stimulate specific brain regions involved in mood regulation. Unlike medication, TMS does not require systemic dosing and is performed during brief outpatient sessions, making it an important consideration for patients who have not responded adequately to antidepressants or who prefer a non-drug treatment approach. While our primary focus for TRD is Spravato therapy, it’s worth knowing the full landscape.
These are supports, not substitutes. Used alongside clinical treatment, they measurably improve outcomes.
Exercise has the strongest evidence. About 150 minutes per week of moderate activity produces antidepressant effects comparable to medication in mild to moderate depression and enhances response in severe cases. Resistance training counts. So does walking. Ten minutes is a real intervention when you’re depressed.
Diet matters through inflammation and gut health. Mediterranean-style eating – vegetables, fish, olive oil, whole grains, nuts – is associated with lower rates of depression; ultra-processed foods and added sugar go the other way. Omega-3 supplementation shows modest add-on benefit.
Sleep is not optional. Insomnia both predicts and perpetuates depression, and treating sleep problems directly often improves mood on its own. Consistent wake times, morning light, and limiting evening alcohol are practical starting points.
Reduce alcohol. Even moderate drinking interferes with sleep architecture and antidepressant effectiveness.
Your surroundings either help or hinder recovery. Consider what you can adjust:
Morning sunlight and movement built into your day
Protected time away from work notifications
Contact with people who don’t require you to perform
Telling one or two people what’s actually happening – depression thrives on secrecy
Small structural changes at work: a different schedule, clearer boundaries, delegating one recurring task
Identifying sources of chronic stress and building a network of friends, family, and peers who understand your journey combats the isolation that so often accompanies TRD.
Years of failed treatment teach a specific kind of hopelessness: the belief that nothing will work because nothing has worked. That belief is a symptom of the illness, not an accurate forecast.
Here’s what the evidence actually shows:
Roughly half to two-thirds of people with TRD achieve meaningful improvement with esketamine
TMS response rates land around 50 to 60 percent
The obstacle for most people isn’t that treatment doesn’t exist – it’s that they stopped looking before reaching the treatments designed for their situation. Reading what other patients have experienced can help when your own hope is running low.
Treatment-resistant depression means your depression hasn’t responded to the first approaches tried – not that it won’t respond at all. A careful re-evaluation often uncovers missed diagnoses, inadequate medication trials, or medical factors that were quietly blocking progress.
Beyond that, Spravato (esketamine), strategic medication changes, evidence-based therapy, and neuromodulation options give most people multiple real paths forward. The goal isn’t just fewer symptoms – it’s returning to a life that feels like yours.
To schedule a new patient consultation in Mesa, call Revival Psychiatry at (480) 613-8162.
About the Author
Erin Jones
